Citing free speech, ex-Intermune CEO asks top court to weigh his wire-fraud conviction

The former CEO of InterMune ($ITMN), Scott Harkonen, who was convicted of wire fraud for issuing a misleading press release about one of the company's drugs, has asked the U.S. Supreme Court to review whether prosecutors violated his First Amendment rights. Report

Suggested Articles

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.

Amid a tough fight in the blood thinner market, J&J and Bayer's Xarelto scored a trial win in treating PAD patients after a recent leg artery surgery.

Experts say it's worth exploring whether a Roche stroke drug could help certain COVID-19 patients.